Editorial Board — Medscape Infectious Diseases

Board Members

  • Kogieleum K. Naidoo, MB ChB, PhD
    • Medical Doctor
      University of Natal
      Head
      Treatment Research Programme
      Centre for the AIDS Programme of Research in South Africa (CAPRISA)
      Durban, South Africa
  • Paul A. Offit, MD
    • University of Pennsylvania School of Medicine
      The Children's Hospital of Philadelphia
      Philadelphia, Pennsylvania
  • Jan E. Patterson, MD
    • The University of Texas Health Long School of Medicine at San Antonio
      University Health System
      San Antonio, Texas
 

Board Member Details

Paul G. Auwaerter, MD
Paul G. Auwaerter, MD

Professor of Medicine, Johns Hopkins University School of Medicine; Clinical Director, Division of Infectious Diseases, Johns Hopkins Hospital, Baltimore, Maryland

Paul G. Auwaerter, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Infectious Diseases Society of America
Received research grant from: MicroBplex

Helen W. Boucher, MD
Helen W. Boucher, MD

Professor of Medicine, Division of Geographic Medicine and Infectious Diseases; Director, Infectious Diseases Fellowship Program; Director, Heart Transplant and Ventricular Assist Device Infectious Diseases Program, Tufts University School of Medicine, Boston, Massachusetts

Helen W. Boucher, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Physicians of Tufts Medical Center; College of the Holy Cross; Infectious Diseases Society of America
Received research grant from: National Institutes of Health

Matthew E. Falagas, MD, MSc, DCs
Matthew E. Falagas, MD, MSc, DCs

Chief, Department of Medicine, Henry Dunant Hospital Center, Athens, Greece

Matthew E. Falagas, MD, MSc, DCs, has disclosed the following relevant financial relationships:
Serve(d) on the advisory board for: AstraZeneca Pharmaceuticals, LP; Infectopharm; Tetraphase; Shionogi & Co., Ltd.; Xellia Pharmaceuticals
Received lecture honoraria from: Cipla Ltd; Merck & Co., Inc.; Pfizer, Inc.
Received research support from: Helperby; Shionogi & Co., Ltd.; Tetraphase; Xellia Pharmaceuticals

Neil Gaffin, MD

Staff Physician, Department of Infectious Diseases, The Valley Hospital; Ridgewood Infectious Disease Associates, Ridgewood, New Jersey

Neil Gaffin, MD, has disclosed no relevant financial relationships.

Kogieleum K. Naidoo, MB ChB, PhD
Kogieleum K. Naidoo, MB ChB, PhD

Honorary Associate Professor, Department of Public Health Medicine, University of KwaZulu-Natal; Medical Doctor; Head, CAPRISA Treatment Research Programme, Centre for the AIDS Programme of Research in South Africa, Durban, South Africa

Kogieleum K. Naidoo, MBChB, PhD, has disclosed no relevant financial relationships.

Paul A. Offit, MD
Paul A. Offit, MD

Professor, Department of Pediatrics, Division of Infectious Diseases, Perelman School of Medicine, University of Pennsylvania; Attending Physician, Department of Pediatrics, Division of Infectious Diseases, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania

Paul A. Offit, MD, has disclosed no relevant financial relationships.

Jan E. Patterson, MD
Jan E. Patterson, MD

Professor, Department of Medicine, Division of Infectious Diseases; Associate Dean for Quality & Lifelong Learning, University of Texas Health, Long School of Medicine at San Antonio; Staff Physician, Consultant, Infectious Diseases, University Health System, San Antonio, Texas

Jan E. Patterson, MD, MS, has disclosed the following relevant financial relationships:
Serve(d) as a distributor for: Young Living
Spouse serve(d) as a consultant for: Basilea; Gilead; Merck; Scynexis
Performed contracted research for: Cidara